At just 16, Tim founded his first web design studio, leading a small team and learning how to turn creative ideas into real products.

After being rejected by 4 universities, he chose a different path, mastering copywriting, data science, and artificial intelligence through independent study.
‍
By 18, he was taught himself machine learning while working full-time in technology B2B sales, where he became a top performer within months.
‍
At 19, Tim built his first AI platform that analyzed stock market data using both fundamental and technical indicators, laying the foundation for his deep understanding of predictive models.
‍
Today, through ABYA Genomics, he is channeling that experience into biotechnology, using AI to model genomics in silico analyses, and build the foundation for a future without traditional clinical trials.

Born with one kidney and living with arthritis since 12, Tim’s personal experience drives his mission to bridge the gap between genomics, AI, and personalized medicine to accelerate breakthroughs that improve lives.